Official recall notice
FDA DrugClass IINotable
FDA Recall: Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifescienc
- Recall date
- 2026-05-27
- Category
- Drug
- FDA class
- Class II
Why it was recalled
Hazard
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
Recommended action
What to do
23,880 bottles
Product description
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit